Dicerna Pharmaceuticals (DRNA) Stock Forecast for 2024–2028. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Dicerna Pharmaceuticals (DRNA) Stock Forecast for 2024–2028. Sell or Buy?

Updated: July 19, 2024 (13:14)

Sector: Healthcare

The share price of Dicerna Pharmaceuticals, Inc. (DRNA) now

This company is DELISTED
Latest session on the 28th of December for
Dicerna Pharmaceuticals, Inc. is negative
Trading Volume: 0
Open: 38.22 /  High: 38.22 /  Low: 38.22
What analysts predict: $
52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For Dicerna Pharmaceuticals stocks, the 50-day moving average is the support level today.

For Dicerna Pharmaceuticals stocks, the 200-day moving average is the support level today.

Are you interested in Dicerna Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Dicerna Pharmaceuticals stock price in 2024, 2025, 2026, 2027, 2028. How much will one Dicerna Pharmaceuticals share be worth in 2024 - 2028?

When should I take profit in Dicerna Pharmaceuticals stock? When should I record a loss on Dicerna Pharmaceuticals stock? What are analysts' forecasts for Dicerna Pharmaceuticals stock? What is the future of Dicerna Pharmaceuticals stock? We forecast Dicerna Pharmaceuticals stock performance using neural networks based on historical data on Dicerna Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Dicerna Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Dicerna Pharmaceuticals shares. This happens once a day.


Historical and forecast chart of Dicerna Pharmaceuticals stock

The chart below shows the historical price of Dicerna Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Dicerna Pharmaceuticals stock price can be found in the table below.

No data

Long-term forecasts by years.

Biopharmaceutical company Dicerna Pharmaceuticals, Inc. specializes in the discovery and development of pharmaceuticals based on the interference of ribonucleic acid (RNAi). The company develops pharmaceuticals using its GalXC RNAi platform to treat liver diseases, including rare diseases, viral infections, chronic liver diseases, and cardiometabolic diseases.

Dicerna Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
Jul 21 38.07 37.19 38.94 4.70
Jul 22 37.77 37.48 38.32 2.24
Jul 23 37.20 36.37 37.97 4.39
Jul 24 36.25 35.57 37.12 4.34
Jul 25 36.52 35.92 37.14 3.42
Jul 26 36.60 36.03 37.33 3.63
Jul 27 36.48 36.09 36.90 2.24
Jul 28 36.99 36.40 37.70 3.57
Jul 29 37.30 36.58 38.01 3.88
Jul 30 36.23 35.43 36.88 4.08
Jul 31 36.76 36.46 37.09 1.72
Aug 01 36.86 36.40 37.53 3.10
Aug 02 37.91 37.33 38.60 3.41
Aug 03 38.06 37.83 38.75 2.44
Aug 04 37.97 37.41 38.82 3.78
Aug 05 38.81 37.88 39.19 3.47
Aug 06 39.03 38.17 39.40 3.22
Aug 07 38.70 37.87 39.03 3.07
Aug 08 38.07 37.27 38.71 3.86
Aug 09 37.55 36.73 38.33 4.36
Aug 10 37.41 36.76 37.75 2.69
Aug 11 36.73 35.95 37.33 3.86
Aug 12 37.65 37.09 38.12 2.77
Aug 13 38.67 37.79 39.16 3.62
Aug 14 38.65 38.30 39.45 3.00
Aug 15 38.71 37.78 38.96 3.14
Aug 16 38.46 38.02 38.69 1.76
Aug 17 37.84 37.25 38.59 3.60
Aug 18 38.25 37.98 38.90 2.42
Aug 19 37.61 37.35 37.90 1.48

Dicerna Pharmaceuticals Daily Price Targets


Dicerna Pharmaceuticals Stock Forecast 07-21-2024.

Forecast target price for 07-21-2024: $38.07.
Negative dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 4.488%.
Pessimistic target level: 37.19
Optimistic target level: 38.94

Dicerna Pharmaceuticals Stock Forecast 07-22-2024.

Forecast target price for 07-22-2024: $37.77.
Negative dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 2.189%.
Pessimistic target level: 37.48
Optimistic target level: 38.32

Dicerna Pharmaceuticals Stock Forecast 07-23-2024.

Forecast target price for 07-23-2024: $37.20.
Negative dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 4.203%.
Pessimistic target level: 36.37
Optimistic target level: 37.97

Dicerna Pharmaceuticals Stock Forecast 07-24-2024.

Forecast target price for 07-24-2024: $36.25.
Negative dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 4.160%.
Pessimistic target level: 35.57
Optimistic target level: 37.12

Dicerna Pharmaceuticals Stock Forecast 07-25-2024.

Forecast target price for 07-25-2024: $36.52.
Positive dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 3.303%.
Pessimistic target level: 35.92
Optimistic target level: 37.14

Dicerna Pharmaceuticals Stock Forecast 07-26-2024.

Forecast target price for 07-26-2024: $36.60.
Positive dynamics for Dicerna Pharmaceuticals shares will prevail with possible volatility of 3.500%.
Pessimistic target level: 36.03
Optimistic target level: 37.33

DRNA (DRNA) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Aug. 41.03 39.13 43.13 9.28
Sep. 40.70 36.28 43.44 16.49
Oct. 38.49 35.90 41.45 13.37
Nov. 36.95 33.34 41.03 18.73
Dec. 34.76 31.20 37.54 16.89

Dicerna Pharmaceuticals forecast for this year


Dicerna Pharmaceuticals Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $41.033. Pessimistic: $39.13. Optimistic: $43.13


Dicerna Pharmaceuticals Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $40.7047. Pessimistic: $36.28. Optimistic: $43.44


Dicerna Pharmaceuticals Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $38.4904. Pessimistic: $35.90. Optimistic: $41.45


Dicerna Pharmaceuticals Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $36.9508. Pessimistic: $33.34. Optimistic: $41.03


Dicerna Pharmaceuticals Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $34.7633. Pessimistic: $31.20. Optimistic: $37.54



Dicerna Pharmaceuticals (DRNA) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 32.54 30.35 35.04 13.37
Feb 33.22 28.96 36.62 20.90
Mar 31.46 28.19 34.43 18.13
Apr 28.94 25.66 32.56 21.19
May 32.60 30.62 34.27 10.65
Jun 32.71 31.45 36.21 13.15
Jul 31.24 29.14 33.74 13.63
Aug 34.54 32.11 36.86 12.89
Sep 33.77 29.99 37.77 20.60
Oct 34.15 30.38 37.92 19.88
Nov 32.02 30.27 34.93 13.34
Dec 30.73 29.70 32.65 9.04

Dicerna Pharmaceuticals (DRNA) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 32.16 29.43 36.12 18.52
Feb 29.69 26.75 32.54 17.81
Mar 27.89 24.41 31.10 21.52
Apr 27.62 26.16 30.00 12.81
May 26.20 23.27 28.01 16.92
Jun 26.71 24.23 29.14 16.86
Jul 29.14 26.39 30.63 13.85
Aug 31.52 29.10 34.70 16.13
Sep 32.93 29.19 35.41 17.56
Oct 34.25 30.19 35.89 15.88
Nov 33.26 29.17 37.04 21.26
Dec 35.55 32.14 39.48 18.59

Dicerna Pharmaceuticals (DRNA) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 32.03 27.98 35.56 21.33
Feb 29.82 27.29 33.02 17.34
Mar 30.73 28.81 34.61 16.76
Apr 29.25 27.66 31.27 11.53
May 33.51 32.01 36.19 11.56
Jun 38.12 34.53 40.63 15.02
Jul 39.22 36.02 42.92 16.08
Aug 39.60 36.11 43.91 17.75
Sep 38.46 34.58 41.54 16.74
Oct 43.13 40.31 44.72 9.88
Nov 43.69 38.17 46.97 18.75
Dec 37.33 35.65 40.73 12.46

Dicerna Pharmaceuticals (DRNA) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 39.42 36.39 43.07 15.52
Feb 37.84 34.27 40.26 14.89
Mar 39.11 35.73 42.62 16.15
Apr 42.18 38.47 46.97 18.10
May 43.46 38.94 47.77 18.49
Jun 48.12 45.27 51.58 12.24
Jul 49.97 44.13 53.48 17.49
Aug 49.57 47.11 55.12 14.53
Sep 47.19 42.96 50.36 14.69
Oct 44.02 42.61 47.82 10.90
Nov 43.10 39.03 47.58 17.97
Dec 41.72 36.45 45.06 19.11

Dicerna Pharmaceuticals information and performance

Dicerna Pharmaceuticals Address

N/A

Market Capitalization: N/A $

Market capitalization of the Dicerna Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of DRNA shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA of Dicerna Pharmaceuticals is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.